McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Latent Raises $80M to Close the Gap Between Diagnosis and Treatment

by Megan Durham | Mar 19, 2026 | Press Releases

Clinical-AI innovation company Latent recently announced the completion of a $80M Series A funding round, led by Spark Capital and Transformation Capital, along with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator. This new capital...

McKesson Ventures Joins Series C Round for Evariant

by Megan Durham | May 10, 2016 | Portfolio News

McKesson Ventures, the healthcare services and information technology arm of McKesson Corp., has made an investment in Evariant, a Farmington, Connecticut-based company that provides customer-relationship management technology to hospitals and health systems. This...

McKesson Ventures Joins Series C Round for Evariant

by Megan Durham | May 10, 2016 | Press Releases

Recent Posts

  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
  • Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
  • BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
  • Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings